The Ministry of Health of the Canary Islands has reported that they have now administered 900,343 doses of vaccines against Covid-19, of the 1,000,270 received, which represents 90.01% of those delivered to the archipelago. Up until yesterday, the immunization of 290,533 people had been achieved, which is 15.53% of the target population (1,871,033 people) of the Canary Islands who have completed their vaccination schedule, having already received two doses of the vaccine, or the Janssen single dose.
There are also 625,559 people who have received at least their first jab which is 33.43% of the target population. During yesterday, Wednesday May 19th, a total of 22,306 vaccines were administered in all the islands, the highest number of inoculations per day to date.
The vaccination schedule is following target population groups depending on the number of people in that group and the availability of vaccines, according to the National Vaccination Strategy. In this sense, the vaccination teams in each health zone are advancing with each population group as the previous one ends without stopping, so that the vaccination process is not slowed down.
Vaccination groups:
In the latest revision of the National Vaccination Strategy, the following vaccination and prioritization groups are established:
STAGE I:
Group 1: COMPLETE
Residents and health and social health personnel who work in residences for the elderly and care for large dependents.
Group 2: COMPLETE
Front-line personnel in the health and social-health field (different from group 1).
Group 3: 100% with one dose and 30.43% with two doses.
Other health and socio-health personnel (not included in group 2)
Group 4: 93.90% immunized with two doses.
People considered highly dependent (grade III) and main carers.
STAGE II:
Group 5: 96.08% with one dose and 63.58% with two doses.
People aged over 65, over 70, over 80+, non-residents of nursing homes.
Group 6: 55.68% with one dose.
Active groups with an essential function for society (Teachers, police, security forces).
Group 7: 63.51% with one dose.
People under 60 with very high risk health conditions.
These include: Hematopoietic stem cell transplantation, solid organ transplantation (and on waiting list for it), people on hemodialysis and peritoneal dialysis, oncohematological diseases, solid organ cancer being treated with cytotoxic, metastatic chemotherapy or with radiotherapy for tumors of thoracic location with risk of pneumonitis, Primary immunodeficiencies, HIV infection with less than 200 cells/ml despite effective ART and undetectable viral load, and Down syndrome (aged 40 and over).
Group 8: 61.40% with one dose.
People between 60 and 65 years of age (born between 1956 and 1961, both inclusive).
Group 9: 15.31% with one dose.
People between 51 and 59 years of age (born between 1962 and 1970, inclusive).
